Skip to content

Clinical study of high added value food material for periodontal disease prevention and improvement

Clinical study of high added value food material for periodontal disease prevention and improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004448
Enrollment
100
Registered
2019-11-19
Start date
2017-06-14
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : - Test group: Extraction of Ligularia stenocephala and wheat sprout (ELW) 300mg capsule (extracted with 50&#37
alcohol), 1 capsule for daily oral intake for 4 weeks _ Control group: Placebo dextrin 300mg capsule with same shape and color with ELW. 1 capsule for daily oral intake for 4 weeks Subjects were rando

Sponsors

Yonsei University Health System, Dental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male or female whose age is in 18~80 years old 2) Subjects who have more than 18 natural teeth 3) Subjects who have sites with probing depth more than 3mm 4) Subjects who have at least two teeth with bleeding on probing in a sextant 5) Subjects who are diagnosed as gingivitis or chronic generalized incipient to moderate periodontitis

Exclusion criteria

Exclusion criteria: 1) Subjects who did not sign on a written consent form. 2) Subjects who are pregnant or lactating 3) Subjects who have uncontrolled systemic diseases like severe hypertension and diabetes 4) Subjects who did not enroll in other clinical studies in recent 3 months 5) Subjects who are intaking antiplatelet or anticoagulant or who have hemorrhagic disease 6) Subjects who had cancer in past 5 years. 7) Subjects who had antibiotic therapy in a recent month 8) Subjects who had periodontal treatment in recent six month, except scaling 9) Subjects who have pathologic appearance (e.g: leukoplakia, lichen planus) 10) Subjects who are decide not to be appropriate in clinician's decision 11) Subjects who had allergy in ingredients for medication 12) Subjects who smokes more than 10 cigarrettes / day

Design outcomes

Primary

MeasureTime frame
Bleeding on probing, Clinical attachment loss

Secondary

MeasureTime frame
Levels of biomarkers in saliva and gingival crevicular fluid;Blood test data

Countries

Korea, Republic of

Contacts

Public ContactInpyo Hong

Yonsei University Health System, Dental Hospital

hip0724@hanmail.net+82-2-2228-8820

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026